PHILADELPHIA--(BUSINESS WIRE)--Revitas is bringing the core capabilities of its market leading Enterprise Revenue Dynamics (ERD) platform for contracts, pricing and compliance to the cloud with the introduction of the RevitasNOW™ offering – a highly scalable, integrated, SaaS solution for organizations desiring a feature-rich ERD solution that can be managed within today’s operating budgets. Leveraging best practices built on more than 10 years of hosting experience, the RevitasNOW offering provides companies with a cost effective SaaS solution for optimizing industry standard applications for contract lifecycle management, the management of complex pricing scenarios, and compliance automation and reporting.
The RevitasNOW technology is built on a unified platform that resides in the cloud, allowing organizations to quickly get up and running at a lower cost without deep IT and capital investments. These capabilities are delivered via the Revitas™ Flex™ technology platform, which provides agility and scalability through a highly integrated environment. The extensible solution is designed to grow its functionality to add full enterprise capabilities if and when they’re needed, enabling the solution to scale along with and support a company’s growth.
“The Revitas suite offers companies an integrated solution for managing the entire lifecycle of a contract and protecting the bottom line. However, complex contracts, pricing concerns, and risk management aren’t limited to companies with significant budgets and resources,” said Al Smith, President and COO, at Revitas. “We created the RevitasNOW solution to give those companies without deep IT budgets a powerful solution to address basic, yet critical, industry issues and reap the operational benefits and cost savings. At the same time, we’ve built this solution to grow with the companies using it, so that as their contracts, pricing, and compliance demands increase, their ERD solution can keep pace.”
RevitasNOW for Life Sciences, now generally available, offers the industry a solution to specifically address the ERD concerns most crucial to life sciences companies, including chargebacks and rebates, advanced membership management, Medicaid rebates, government pricing and contract management. The software’s functionality and ability to effectively scale is essential for emerging companies in this industry, which often see a quick advent of hyper-growth after FDA approval of their drugs currently in clinical trials. In just 12-18 months after approval, drug sales can transform mid-market life sciences companies into multi-billion dollar organizations with proportional ERD concerns. RevitasNOW for Life Sciences enables users to upgrade functionality to handle the growing concerns that accompany such jumps in revenue – as well as gain business intelligence, validate rebate claims, and manage increasingly complex contracts.
“All life sciences companies deal with the same complex issues when it comes to contracting, pricing and compliance scenarios. However, not all companies have the same deep pockets when it comes to expenditures on technology,” said Eric Newmark, Program Director of Life Sciences at IDC Health Insights. “There is added value for any company who can invest in a solution early in their lifecycle at minimal cost and have its functionality grow as needed.”
About Revitas
Revitas, the leader in Enterprise Revenue Dynamics, delivers integrated solutions for contracts, pricing, and compliance that drive higher profitability and lower risk. Revitas empowers companies to optimize contract performance by defining, managing, and analyzing complex, multi-tier pricing incentives and enables positive proof of compliance with commercial, financial, and industry requirements. Powered by the secure, scalable, and standards-based Flex™ platform, Revitas™ applications speed time to market and improve visibility across B2B relationships. Hundreds of organizations across the most highly regulated and challenging industries leverage Revitas integrated solutions to save money, make money, and reduce risk. For details, visit www.revitasinc.com or http://blog.revitasinc.com/.